Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease

被引:251
|
作者
Silvestrini, M
Pasqualetti, P
Baruffaldi, R
Bartolini, M
Handouk, Y
Matteis, M
Moffa, F
Provinciali, L
Vernieri, F
机构
[1] Polytech Univ Marche, Neurol Clin, I-60020 Ancona, Italy
[2] AfaR Fatebenefratelli Hosp, Dept Neurosci, Rome, Italy
[3] IRCCS Fdn Santa Lucia, Rome, Italy
[4] Neurol Clin, Rome, Italy
关键词
dementia; hemodynamics; ultrasonography; Doppler; transcranial;
D O I
10.1161/01.STR.0000206439.62025.97
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - The aim of this study was to explore the possible contribution of alterations in cerebral hemodynamics to the evolution of cognitive impairment in patients with Alzheimer disease ( AD). Method - Fifty-three patients with AD were investigated. The evolution of cognitive decline over 12 months was evaluated by means of changes in Mini Mental State Examination (MMSE) and AD Assessment Scale for Cognition (ADAS-Cog) scores. Demographic characteristics, vascular risk profile, pharmacological treatment, and presence of white matter lesions were assessed at entry. Further, a basal evaluation of cerebrovascular reactivity to hypercapnia was measured with transcranial Doppler ultrasonography using the breath-holding index (BHI). Results - Of all the variables considered, both MMSE and ADAS-Cog changes had the highest correlation with BHI, followed by age and diabetes. After subdividing both cognitive measures reductions into bigger and smaller-than-average decline ( 2 points for MMSE; 5 points for ADAS-Cog), multiple logistic regression indicated BHI as the sole significant predictor of cognitive decline. Conclusions - These results show an association between impaired cerebral microvessels functionality and unfavorable evolution of cognitive function in patients with AD. Further research is needed to fully establish whether altered cerebral hemodynamics may be considered an independent factor in sustaining cognitive decline progression or an effect of pathological processes involved in AD.
引用
收藏
页码:1010 / 1015
页数:6
相关论文
共 50 条
  • [1] Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease
    Gary Small
    Timo Erkinjuntti
    Alexander Kurz
    Sean Lilienfeld
    CNS Drugs, 2003, 17 : 905 - 914
  • [2] Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease
    Richiardi, Jonas
    Monsch, Andreas U.
    Haas, Tanja
    Barkhof, Frederik
    Van de Ville, Dimitri
    Radue, Ernst W.
    Kressig, Reto W.
    Haller, Sven
    NEUROBIOLOGY OF AGING, 2015, 36 (01) : 33 - 41
  • [3] Distinct pathways for cognitive decline in the presence of Alzheimer's disease pathology or cerebrovascular disease
    Cohen, Ann D.
    BRAIN, 2016, 139 : 2340 - 2341
  • [4] Citicoline May Prevent Cognitive Decline in Patients with Cerebrovascular Disease
    Almeria, Marta
    Alvarez, Ignacio
    Molina-Seguin, Jessica
    Besora, Sarah
    Buongiorno, Mariateresa
    Romero, Silvia
    Casas, Laura
    Cano, Cristina
    Castejon, Judith
    Arribas, Sonia
    Krupinski, Jerzy
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1093 - 1102
  • [5] Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease
    Frank, Brandon
    Ally, Madeline
    Tripodis, Yorghos
    Puzo, Christian
    Labriolo, Caroline
    Hurley, Landon
    Martin, Brett
    Palmisano, Joseph
    Chan, Lawrence
    Steinberg, Eric
    Turk, Katherine
    Budson, Andrew
    O'Connor, Maureen
    Au, Rhoda
    Qiu, Wei Qiao
    Goldstein, Lee
    Kukull, Walter
    Kowall, Neil
    Killiany, Ronald
    Stern, Robert
    Stein, Thor
    McKee, Ann
    Mez, Jesse
    Alosco, Michael
    NEUROLOGY, 2022, 98 (24) : E2454 - E2464
  • [6] Rates of Cognitive Decline in 100 Patients With Alzheimer Disease
    Miyakawa-Liu, Monica
    Feehan, Amy K.
    Pai, Shannon
    Garcia-Diaz, Julia
    OCHSNER JOURNAL, 2022, 22 (02): : 129 - 133
  • [7] Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review
    Scarth, Morgan
    Rissanen, Ina
    Scholten, Rob J. P. M.
    Geerlings, Mirjam, I
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (03) : 1089 - 1111
  • [8] Epidemiology of cerebrovascular disease related cognitive decline
    Qiu, CX
    Fratiglioni, L
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 105 - 110
  • [9] Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease
    Silvestrini, Mauro
    Gobbi, Beatrice
    Pasqualetti, Patrizio
    Bartolini, Marco
    Baruffaldi, Roberto
    Lanciotti, Chiara
    Cerqua, Raffaella
    Altamura, Claudia
    Provinciali, Leandro
    Vernieri, Fabrizio
    NEUROBIOLOGY OF AGING, 2009, 30 (08) : 1177 - 1183
  • [10] Cerebrovascular disease in suspected non-Alzheimer's pathophysiology and cognitive decline over time
    Saridin, Francis Nicole
    Chew, Kimberly Ann
    Reilhac, Anthonin
    Gyanwali, Bibek
    Villaraza, Steven Gayoles
    Tanaka, Tomotaka
    Scheltens, Phillip
    van der Flier, Wiesje M.
    Chen, Christopher Li Hsian
    Hilal, Saima
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (07) : 1922 - 1929